Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

1.

Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.

Heo SH, Shin SS, Kim JW, Lim HS, Jeong YY, Kang WD, Kim SM, Kang HK.

Korean J Radiol. 2013 Jul-Aug;14(4):616-25. doi: 10.3348/kjr.2013.14.4.616. Epub 2013 Jul 17.

PMID:
23901319
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].

Wu B, Huang X, Peng W, Gu Y, Yang T, Mao J, Ke G, Wu X.

Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):115-9. Chinese.

PMID:
24796459
[PubMed - indexed for MEDLINE]
3.

Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.

Kang Y, Choi SH, Kim YJ, Kim KG, Sohn CH, Kim JH, Yun TJ, Chang KH.

Radiology. 2011 Dec;261(3):882-90. doi: 10.1148/radiol.11110686. Epub 2011 Oct 3.

PMID:
21969667
[PubMed - indexed for MEDLINE]
4.

Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images.

Downey K, Riches SF, Morgan VA, Giles SL, Attygalle AD, Ind TE, Barton DP, Shepherd JH, deSouza NM.

AJR Am J Roentgenol. 2013 Feb;200(2):314-20. doi: 10.2214/AJR.12.9545.

PMID:
23345352
[PubMed - indexed for MEDLINE]
5.

Evaluation of diffusion-weighted imaging as a predictive marker for tumor response in patients undergoing chemoradiation for postoperative recurrences of cervical cancer.

Chopra S, Verma A, Kundu S, Engineer R, Medhi S, Mahantshetty U, Gupta S, Shrivastava SK.

J Cancer Res Ther. 2012 Jan-Mar;8(1):68-73. doi: 10.4103/0973-1482.95177.

PMID:
22531517
[PubMed - indexed for MEDLINE]
Free Article
6.

Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.

Liu Y, Bai R, Sun H, Liu H, Wang D.

J Comput Assist Tomogr. 2009 Nov-Dec;33(6):858-62. doi: 10.1097/RCT.0b013e31819e93af.

PMID:
19940650
[PubMed - indexed for MEDLINE]
7.

Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Chu HH, Choi SH, Ryoo I, Kim SC, Yeom JA, Shin H, Jung SC, Lee AL, Yoon TJ, Kim TM, Lee SH, Park CK, Kim JH, Sohn CH, Park SH, Kim IH.

Radiology. 2013 Dec;269(3):831-40. doi: 10.1148/radiol.13122024. Epub 2013 Oct 28.

PMID:
23771912
[PubMed - indexed for MEDLINE]
8.

Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation.

Somoye G, Harry V, Semple S, Plataniotis G, Scott N, Gilbert FJ, Parkin D.

Eur Radiol. 2012 Nov;22(11):2319-27. doi: 10.1007/s00330-012-2496-0. Epub 2012 Jun 1.

PMID:
22653281
[PubMed - indexed for MEDLINE]
9.

Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.

Yabuuchi H, Hatakenaka M, Takayama K, Matsuo Y, Sunami S, Kamitani T, Jinnouchi M, Sakai S, Nakanishi Y, Honda H.

Radiology. 2011 Nov;261(2):598-604. doi: 10.1148/radiol.11101503. Epub 2011 Aug 18.

PMID:
21852569
[PubMed - indexed for MEDLINE]
10.

Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma.

Srinivasan A, Chenevert TL, Dwamena BA, Eisbruch A, Watcharotone K, Myles JD, Mukherji SK.

J Comput Assist Tomogr. 2012 Jan-Feb;36(1):131-7. doi: 10.1097/RCT.0b013e3182405435.

PMID:
22261783
[PubMed - indexed for MEDLINE]
11.

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

Harry VN, Semple SI, Gilbert FJ, Parkin DE.

Gynecol Oncol. 2008 Nov;111(2):213-20. doi: 10.1016/j.ygyno.2008.07.048. Epub 2008 Sep 6.

PMID:
18774597
[PubMed - indexed for MEDLINE]
12.

Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.

Vandecaveye V, Dirix P, De Keyzer F, Op de Beeck K, Vander Poorten V, Hauben E, Lambrecht M, Nuyts S, Hermans R.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1098-107. doi: 10.1016/j.ijrobp.2011.02.044. Epub 2011 Apr 20.

PMID:
21514067
[PubMed - indexed for MEDLINE]
13.

Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.

Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O.

Radiology. 2014 Apr;271(1):143-52. doi: 10.1148/radiol.13130973. Epub 2013 Dec 12.

PMID:
24475824
[PubMed - indexed for MEDLINE]
14.

Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer.

Yoshida S, Koga F, Kobayashi S, Ishii C, Tanaka H, Tanaka H, Komai Y, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e21-7. doi: 10.1016/j.ijrobp.2011.11.065. Epub 2012 Mar 11.

PMID:
22414281
[PubMed - indexed for MEDLINE]
15.

Diffusion-weighted MRI in cervical cancer.

McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA.

Eur Radiol. 2008 May;18(5):1058-64. doi: 10.1007/s00330-007-0843-3. Epub 2008 Jan 12.

PMID:
18193428
[PubMed - indexed for MEDLINE]
16.

True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.

Song YS, Choi SH, Park CK, Yi KS, Lee WJ, Yun TJ, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Jahng GH, Chang KH.

Korean J Radiol. 2013 Jul-Aug;14(4):662-72. doi: 10.3348/kjr.2013.14.4.662. Epub 2013 Jul 17.

PMID:
23901325
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, Cai SJ, Zhang Z.

World J Gastroenterol. 2013 Sep 7;19(33):5520-7. doi: 10.3748/wjg.v19.i33.5520.

PMID:
24023496
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.

Jung SH, Heo SH, Kim JW, Jeong YY, Shin SS, Soung MG, Kim HR, Kang HK.

J Magn Reson Imaging. 2012 Jan;35(1):110-6. doi: 10.1002/jmri.22749. Epub 2011 Oct 11.

PMID:
21989997
[PubMed - indexed for MEDLINE]
19.

Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging.

Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, Beets GL, Caseiro-Alves F, Beets-Tan RG.

Radiology. 2011 Sep;260(3):734-43. doi: 10.1148/radiol.11102467. Epub 2011 Jun 14.

PMID:
21673229
[PubMed - indexed for MEDLINE]
20.

[Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma].

Zhang Y, Liang BL, Gao L, Ye RX, Shen J, Zhong JL.

Ai Zheng. 2007 May;26(5):508-12. Chinese.

PMID:
17672942
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk